Prevention of predictable Raynaud's phenomenon by sublingual nifedipine.
Miller
F W
FW
Love
L A
LA
D000286:Administration, Sublingual; D000328:Adult; D005260:Female; D006801:Humans; D009543:Nifedipine / Q000008:administration & dosage*; D011928:Raynaud Disease / Q000188:drug therapy*
D009543:Nifedipine